[Organ tolerance and incomplete bone marrow chimera in dogs]
- PMID: 376244
[Organ tolerance and incomplete bone marrow chimera in dogs]
Abstract
Cyclophosphamide-induced chimeras develop organ tolerance as do radiation chimeras, as long as hemopoietic cells of donor origin are detectable, independent of the degree of chimerism (n = 7). 4 of 7 dogs with reversion of chimerism rejected their kidney grafts within 11 to 29 days. Three of them, however, retained their kidney grafts permanently indicating that a transient chimerism of a few months duration may be sufficient for induction of tolerance to marrow donor organs in Cy-chimeras. The results suggest that the reversion of chimerism in Cy-chimeras may be due to different mechanisms either immunological rejection or a non-immunological substitution of the grafted marrow by the host's own hemopoiesis.
Similar articles
-
Kidney transplantation following treatment with cyclophosphamide and bone marrow grafting.Transplant Proc. 1977 Mar;9(1):261-3. Transplant Proc. 1977. PMID: 325763
-
Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.Circulation. 1998 Nov 10;98(19 Suppl):II163-8; discussion II168-9. Circulation. 1998. PMID: 9852899
-
Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.Biol Blood Marrow Transplant. 2001;7(12):646-55. doi: 10.1053/bbmt.2001.v7.pm11787527. Biol Blood Marrow Transplant. 2001. PMID: 11787527
-
Chimerism and tolerance: from freemartin cattle and neonatal mice to humans.Hum Immunol. 1997 Feb;52(2):155-61. doi: 10.1016/S0198-8859(96)00290-X. Hum Immunol. 1997. PMID: 9077564 Review.
-
Cyclophosphamide-induced chimera-type tolerance to allografts: an overview of drug-induced immunological tolerance.Fukuoka Igaku Zasshi. 1990 Jan;81(1):20-39. Fukuoka Igaku Zasshi. 1990. PMID: 2182492 Review.